Leukocytosis is an increase in the content of leukocytes in the peripheral blood above 9000 in 1 μl (9x109 / l). It is observed in a wide range of nosologies, especially bacterial and viral infections, systemic inflammatory pathologies of a rheumatic nature. There are no specific clinical manifestations. Symptoms are determined by the cause, i.e. disease, against the background of which leukocytosis developed. The level of leukocytes is measured when taking venous or capillary blood in the morning 12 hours after the last meal. The white blood cell count is part of a complete blood count. To correct leukocytosis, the underlying disease is treated.
Leukocytosis is divided according to various criteria. According to the biological significance, a physiological and pathological increase in leukocytes in the blood is distinguished. Physiological leukocytosis does not cause any harm and is observed in every healthy person under certain circumstances - during intense muscular work (myogenic), 2-3 hours after a meal (alimentary), in the second trimester of pregnancy (gestational). Diseases are the cause of pathological leukocytosis. According to the degree of increase in the level of leukocytes, there are:
In addition to the level of leukocytosis, what type of leukocytes has gone beyond the normal range is important. Depending on the type of leukocytes, the following types of leukocytosis are distinguished:
The most common cause of leukocytosis are various infections (bacterial, viral, parasitic). Since the main function of all leukocytes is to maintain anti-infective immunity, the presence of a foreign pathogen in the body is accompanied by a reactive increase in white blood cells in the blood. Moreover, a certain type of microorganism causes various types of leukocytosis.
The cause of leukocytosis is often chronic systemic inflammatory processes. The exact pathogenetic mechanisms of the increase in leukocytes in these pathologies are still unknown. It is assumed that the mediators and cytokines formed during rheumatic inflammation stimulate the production of leukocytes in the bone marrow. This mainly applies to the following rheumatic diseases:
In arthritis and diffuse connective tissue diseases, leukocytosis is usually moderate. With systemic vasculitis with necrotizing inflammation in the vascular wall, leukocytosis can reach high numbers.
This is the main cause of eosinophilic leukocytosis. Ingestion of an allergen causes IgE-mediated degranulation of mast cells with the release of mediators of allergic inflammation - leukotrienes, histamine, etc. One of the main functions of eosinophils is to suppress the production of inflammatory mediators, so any allergic reaction is accompanied by an increase in the level of eosinophils.
The maximum level of eosinophilia is reached at the moment of exacerbation of the allergic reaction, then it gradually decreases as the symptoms regress and returns to normal levels in remission. In most allergic diseases (bronchial asthma, rhinoconjunctivitis), moderate leukocytosis is observed. Only with the development of systemic reactions (Stevens-Jones syndrome, DRESS syndrome) can high leukocytosis occur.
Malignant myeloproliferative (leukemia, polycythemia) and lymphoproliferative (lymphoma) pathologies are considered the main cause of hyperleukocytosis. It is caused by oncological transformation of bone marrow and lymphatic tissue stem cells, followed by overproduction of leukocytes. With leukemia, neutrophilic, monocytic or eosinophilic leukocytosis is observed, with lymphomas - lymphocytosis.
In acute leukemia, in addition to leukocytosis, there are signs such as leukemic failure, which implies the presence of only mature leukocytes and blast cells and the absence of intermediate forms (metamyelocytes), basophilic-eosinophilic association (a simultaneous sharp increase in basophils and eosinophils). Leukocytosis increases slowly over several years. It reaches high numbers (up to 10,000) and gradually decreases under the influence of chemotherapy.
Leukocytosis is detected during a clinical blood test. Since there are quite a few reasons for an increase in the level of leukocytes, you should first consult a general practitioner. The doctor collects a detailed history, conducts a physical examination of the patient, including measuring body temperature, examining the skin and mucous membranes, etc. Based on the data obtained, in order to confirm the disease that caused leukocytosis, the following studies are prescribed:
The leukocyte formula allows you to determine the percentage of different types of leukocytes
There is no symptomatic treatment for leukocytosis. To normalize the level of white blood cells, it is necessary to fight the underlying pathology that caused leukocytosis. With a slight leukocytosis during the recovery period from an infectious disease, no medical intervention is needed. However, even a moderate increase in leukocytes in the blood, which persists for a long time, requires a specialist consultation to find out the cause.
For the treatment of diseases accompanied by leukocytosis, antibacterial, antiviral, anthelmintic drugs are used. If the high content of leukocytes is due to rheumatological pathology, agents that suppress the inflammatory process (glucocorticosteroids, immunosuppressants) are used. Allergic reactions are effectively stopped by antihistamines and corticosteroids.
If the cause of leukocytosis was malignant hematological diseases, a long course of chemotherapy is required, and in some cases, allogeneic bone marrow transplantation. Suppurative processes (phlegmon, abscesses) are subject to surgical intervention, which involves dissection of soft tissues, washing and drainage of the focus. Endocarditis may require valve repair or replacement.
Leukocytosis alone cannot be a predictor of sequelae or complications. It is impossible to predict the prognosis and risk of death from it. The outcome directly depends on the cause, i.e. the disease that caused leukocytosis, as well as the degree of its severity. For example, an acute respiratory viral infection almost always proceeds benignly, ends in complete recovery and does not affect life expectancy in any way. Pathologies such as systemic vasculitis, hemoblastoses are characterized by a high percentage of mortality. Therefore, at any level of increase in leukocytes in the blood, a thorough examination is indicated, aimed at finding out the cause and timely initiation of treatment.